A Resolution urging the Congress of the United States to pass H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress.

This Pennsylvania House resolution (HR 157) urges the U.S. Congress to pass H.R. 3023 (or similar legislation) during the 119th Congress, which would require the Department of Veterans Affairs and Department of Defense to provide stellate ganglion block (SGB) therapy to veterans and military members with PTSD. SGB is a low-risk neck injection procedure that targets nerves controlling stress responses, potentially alleviating symptoms like anxiety and hyperarousal. The resolution cites that 23% of recent veterans and 12-15% of older veterans have PTSD diagnoses, with current treatments helping only 40% of patients. It emphasizes SGB's decades-long use and support from veterans' organizations as a potential treatment option.